China approves first oral GLP-1 weight-loss pill
China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
What men need to know after a major update to prostate cancer guidelines
United Kingdom
-
SpaceX's giant rocket may leave NASA in the dust
United States
-
The US and Mexico are on the verge of forfeiting a major health victory. Here's what to know
United Kingdom
-
Machine-learning models accurately predict mortality after a heart attack
United Kingdom
-
Your brain may reveal your Alzheimer’s risk before symptoms appear
United Kingdom
-
Broad genomic sequencing extends survival in advanced lung cancer patients
United Kingdom
-
DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancer
United Kingdom
-
Single-cell spatial atlas profiles 850,000 cells across breast cancer progression
United Kingdom